Quarterly report pursuant to Section 13 or 15(d)

Revenue from Contracts with Customers (Revenue from Customers by Products) (Details)

v3.22.2
Revenue from Contracts with Customers (Revenue from Customers by Products) (Details) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Revenue, Major Customer [Line Items]        
Revenues $ 9,602,195 $ 17,655,592 $ 36,765,721 $ 45,613,068
FC2 Segment [Member]        
Revenue, Major Customer [Line Items]        
Revenues 9,602,195 17,655,592 36,765,721 44,750,237
PREBOOST Segment [Member]        
Revenue, Major Customer [Line Items]        
Revenues       862,831
U.S. Prescription Channel Segment [Member] | FC2 Segment [Member]        
Revenue, Major Customer [Line Items]        
Revenues 6,736,158 13,501,862 29,900,890 32,916,343
Global Public Health Sector [Member] | FC2 Segment [Member]        
Revenue, Major Customer [Line Items]        
Revenues $ 2,866,037 $ 4,153,730 $ 6,864,831 $ 11,833,894